CLONING OF NOVEL ENZYMES THAT MODIFY LIPID A
修饰脂质 A 的新型酶的克隆
基本信息
- 批准号:6136267
- 负责人:
- 金额:$ 3.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-01 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The outer leaflet of the outer membranes of Gram-negative bacteria is almost entirely composed of lipopolysaccharide (LPS) and acts as an efficient permeability barrier against antibacterial agents. Lipid A (endotoxin) functions as the hydrophobic anchor of LPS and is the bioactive component of the molecule leading to Gram-negative septic shock and death. The enzymatic machinery required for lipid A biosynthesis is well understood, however, the enzymes responsible for certain regulated modifications of lipid A remain unknown. These modifications include the addition of 4-aminoarabinose, phosphoethanoiamine, palmitate, 2- hydroxymyristate, phosphate, and the removal of specific fatty acyl chains. It is now known that some of these modifications are important for survival of the bacterium from the host innate immune system. Therefore, understanding the enzymology of these modifications will not only facilitate the understanding of lipid A biosynthesis but will lay the foundation of new molecular insights into pathogenesis. The current study focuses on (I) the characterization of enzymes involved in the addition of 4-aminoarabinose and deacylation of lipid A; (II) structural analysis of the enzymatic products and analysis of their endotoxic activities; and (III) the cloning of these novel genes.
革兰氏阴性菌外膜的外小叶几乎完全由脂多糖(LPS)组成,并作为抗抗菌剂的有效渗透屏障。脂质A(内毒素)作为LPS的疏水性锚发挥作用,并且是导致革兰氏阴性脓毒性休克和死亡的分子的生物活性组分。脂质A生物合成所需的酶机制是众所周知的,然而,负责脂质A的某些调节修饰的酶仍然未知。这些修饰包括添加4-氨基阿拉伯糖、磷酸乙醇胺、棕榈酸酯、2-羟基肉豆蔻酸酯、磷酸酯和去除特定的脂肪酰基链。现在已知这些修饰中的一些对于细菌从宿主先天免疫系统中存活是重要的。因此,了解这些修饰的酶学不仅有助于了解脂质A的生物合成,而且将为发病机制的新分子见解奠定基础。目前的研究重点是(I)参与添加4-氨基阿拉伯糖和脂质A脱酰化的酶的表征;(II)酶产物的结构分析及其内毒素活性分析;和(III)这些新基因的克隆。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Stephen Trent其他文献
Michael Stephen Trent的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Stephen Trent', 18)}}的其他基金
The role of cardiolipin in the biogenesis of the Gram-negative bacterial cell envelope
心磷脂在革兰氏阴性细菌细胞包膜生物发生中的作用
- 批准号:
10731444 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Synthesis and transport of outer membrane components across the Gram-negative cell envelope
外膜成分的合成和跨革兰氏阴性细胞包膜的运输
- 批准号:
10680968 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
多重耐药病原体鲍曼不动杆菌的细胞包膜
- 批准号:
10113527 - 财政年份:2020
- 资助金额:
$ 3.24万 - 项目类别:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
多重耐药病原体鲍曼不动杆菌的细胞包膜
- 批准号:
10542396 - 财政年份:2020
- 资助金额:
$ 3.24万 - 项目类别:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
多重耐药病原体鲍曼不动杆菌的细胞包膜
- 批准号:
10328269 - 财政年份:2020
- 资助金额:
$ 3.24万 - 项目类别:
Molecular mechanisms required for the maintenance of the gram-negative outer membrane
维持革兰氏阴性外膜所需的分子机制
- 批准号:
10159193 - 财政年份:2018
- 资助金额:
$ 3.24万 - 项目类别:
Molecular mechanisms required for the maintenance of the gram-negative outer membrane
维持革兰氏阴性外膜所需的分子机制
- 批准号:
10403653 - 财政年份:2018
- 资助金额:
$ 3.24万 - 项目类别:
Molecular mechanisms required for the maintenance of the gram-negative outer membrane
维持革兰氏阴性外膜所需的分子机制
- 批准号:
9917747 - 财政年份:2018
- 资助金额:
$ 3.24万 - 项目类别:
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
新型疫苗平台的开发:表面抗原/佐剂疫苗工程(SAAVE)
- 批准号:
9899172 - 财政年份:2017
- 资助金额:
$ 3.24万 - 项目类别:
相似海外基金
Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
- 批准号:
BB/Y003756/1 - 财政年份:2024
- 资助金额:
$ 3.24万 - 项目类别:
Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
- 批准号:
MR/Y503435/1 - 财政年份:2024
- 资助金额:
$ 3.24万 - 项目类别:
Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
- 批准号:
10561406 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
- 批准号:
22KJ1113 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
- 批准号:
BB/X001504/1 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
- 批准号:
10584620 - 财政年份:2022
- 资助金额:
$ 3.24万 - 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
- 批准号:
576016-2022 - 财政年份:2022
- 资助金额:
$ 3.24万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
- 批准号:
10657417 - 财政年份:2022
- 资助金额:
$ 3.24万 - 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
- 批准号:
10389517 - 财政年份:2022
- 资助金额:
$ 3.24万 - 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
- 批准号:
RGPIN-2019-07122 - 财政年份:2022
- 资助金额:
$ 3.24万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




